Kowalski A, Björnsson E, Sørensen M. "一种的合成方法" [P]. European Patent, EP 3866123 A1, 2018-03-15.
Davis P L, Hughes D C, Roberts E F. "Method for the Synthesis of Methyl 1-(5-(3-bromothiophen-2-yl)-3-cyano-1H-pyrrol-2-yl)piperidine-4-carboxylate" [P]. US Patent, US 9608802 B2, 2016-06-13.
发明人徐明华,杨光,罗永刚. "A Process for Preparing High-Purity Methyl 1-(5-(3-bromothiophen-2-yl)-3-cyano-1H-pyrrol-2-yl)piperidine-4-carboxylate" [P]. 中国发明专利, 专利号 CN 112857101 A, 授权公告日 2021-01-09.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 1947, 1711-1720.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2023, 2218, (3), 6931-6939.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 1-(5-(3-bromothiophen-2-yl)-3-cyano-1H-pyrrol-2-yl)piperidine-4-carboxylate Using HRMS and NMR". Chromatographia, 2010, 2372, (5), 1042-1068.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2024, 1969, (8), 5528-5550.